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The Role of Physical Activity on 
Insulin Resistance-Associated 
Endothelial Dysfunction
Shruti M. Gandhi, Eric S. Nylen and Sabyasachi Sen
Abstract
Enhanced physical activity and cardiorespiratory fitness significantly impact 
morbidity and mortality across the spectrum of noncommunicative chronic illnesses 
experienced by modern lifestyles. Physical activity itself prompts an intricate inter-
play of physiological responses across vital organ systems including microvascular 
adaptations to optimize nutrient, oxygen, and hormone delivery, some of which 
involves insulin-mediated regulation. Insulin has been known to act on the vascula-
ture in multiple ways by its effects on endothelium and skeletal muscle blood flow. 
This is important to understand as it has implications for conditions associated with 
insulin resistance (IR) such as obesity, metabolic syndrome, prediabetes, diabetes, 
and polycystic ovarian syndrome among others. These conditions are associated 
with increased morbidity and mortality contributed by endothelial dysfunction via 
increased atherosclerosis, hypertension, and increased free fatty acid levels. In this 
chapter, we will discuss the effects of insulin on the vasculature, IR on the endothe-
lium, and lastly, what impact physical activity may have on such processes.
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1. Introduction
The mechanisms behind the clinical improvements following exercise and the 
possible roles of endothelium and adipose tissue towards tissue re-modeling and 
regeneration are poorly understood.
The cellular changes resulting from exercise in overweight or obese population 
are not fully documented. However, the incidence of overweight and obese popula-
tion who are insulin resistant is gradually increasing. There seems to be an intimate 
relationship between fat hypertrophy, fat inflammation, and vascular supply in 
metabolic syndrome states such as prediabetes. The vasculature and endothelium in 
metabolic syndrome or subjects with prediabetes and insulin resistance are prone to 
ROS accumulation and inflammation. Exercise appears to improve endothelial dys-
function in insulin resistant cohort though cell-based data is lacking. The favorable 
impact of exercise on cardio-metabolic health depends in part on the concomitant 
exercise-induced reduction of adiposity and fat-based inflammation and insulin 
resistance.
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2. Insulin as a vascular hormone
Insulin acts as a vascular hormone, mediating its action by several mechanisms 
including its effect on cardiac output, endothelium, type and location of vessel, and 
skeletal muscle [1].
Cardiac output: it has been established that insulin combined with glucose infu-
sion causes an increase in cardiac output (CO) [2]. High concentrations of insulin 
in humans of 70 μU/mL cause a 15% rise in CO by increasing heart rate and stroke 
volume [3]. The rise in CO is associated with a decrease in mean arterial pressure 
and in turn, a reduction in systemic vascular resistance.
Endothelium: insulin directly acts on the vascular endothelium by binding to 
insulin receptors, insulin-like growth factor I (IGF-I) receptors and hybrid insulin/
IGF-I receptors [4]. With the binding of insulin to these endothelial receptors, both 
vasodilator (i.e., nitric oxide, NO) and vasoconstrictor (i.e., endothelin 1, ET-1) 
substances are released to balance vascular tone. NO causes vasodilation of the 
vessels via the activation of insulin receptor substrate-1 (IRS-1) leading to phos-
phatidylinositol 3-kinase (PI-3 kinase)/protein kinase B (Akt.) phosphorylation of 
Figure 1. 
Pathway of insulin-mediated release of nitric oxide (NO) and endothelin-1 (ET-1), two peptides that 
influence vasomotor tone and risk of atherosclerosis. Insulin directly affects the vascular endothelium by binding 
to receptors present on the endothelium which expresses not only insulin receptors but also insulin-like growth 
factor I (IGF-I) receptors and hybrid insulin/IGF-I receptors. These hybrid receptors are expressed 5- to 10-fold 
higher concentration than insulin receptors. Potentially, an over-abundance of IGF-1 receptor may result in 
vascular insulin resistance by promoting hybrid receptor formation which does not respond to physiological 
insulin concentrations while decreasing insulin receptor availability. As described in the text, insulin initiates 
an intracellular cascade of steps resulting in NO or ET-1. GLUT-4 transports glucose across the cellular 
membrane following insulin activation or muscle contraction via a complex of intermediary substrates. The 
former is initiated by the PI3K pathway, while muscle contraction by a PI3K independent pathway.
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endothelial NO synthase (eNOS) whereas the ET-1 signaling pathway involves the 
mitogen activated protein kinase (MAPK) (Figure 1). During states of high insulin 
concentrations, as seen in euglycemic hyperinsulinemic clamp studies or postpran-
dially, insulin’s vasodilatory effect through NO predominates. NO not only decreases 
vascular tone but also decreases vascular smooth muscle cell (VSMC) proliferation 
and reduces binding of inflammatory cells and platelet aggregation [5].
Type and location of vessels: insulin’s action on the vasculature varies depending 
on its site of action along the arterial tree which can include the conduit arteries, the 
resistance arterioles, precapillary arterioles and the capillaries (Table 1). It also acts 
on the skeletal muscle vasculature and can have effects locally.
The conduit arteries are large arteries which regulate arterial compliance in 
response to the ejection volume and stretch in order to maintain blood pressure. 
Insulin increases compliance by vasodilation of these vessels in response to NO 
release. In human studies with insulin infusion, the responsiveness of the femoral 
artery to methacholine-induced vasodilation is increased [4].
The resistance arterioles regulate blood pressure and total blood flow to tissues. 
They determine vascular resistance as a change in the size of the vessel (lumen 
size) can significantly increase or decrease resistance and thus the amount of blood 
supply to the tissues. Insulin via NO production causes dilation of these vessels, 
decreases resistance, and increases blood flow.
The microvasculature including the terminal arterioles, capillary networks and 
venules regulate insulin delivery to muscle tissues. Insulin action here promotes 
glucose uptake, recruitment of muscle vasculature and its own trans-endothelial 
transport [4]. This allows for exchange of nutrients, oxygen, and hormones to the 
muscle with removal of metabolic waste.
Skeletal muscle: during exercise, skeletal muscle blood flow, capillary recruit-
ment, and GLUT4 translocation to the sarcolemma and T-tubules are augmented 
which is essential for glucose uptake and oxidation. Insulin targets the skeletal 
muscle by increasing blood flow and glucose uptake, the latter mediated by translo-
cation of GLUT4 transporters to the sarcolemma and transverse tubules as well as to 
the surface of the cell (independent of insulin).
3. Insulin resistance (IR) and vasculature
Insulin resistance is characterized by a state of compensatory hyperinsulinemia 
due to changes in insulin secretion and/or insulin clearance [6] leading to mild 
forms of glucose intolerance, dyslipidemia (high triglycerides, low HDL, small 
Vessel Role Insulin action Mechanism
Conduit 
arteries
Regulate arterial 
compliance, blood pressure
Increases relaxation, 
increases compliance
Likely NO
Resistance 
arterioles
Determines vascular 
resistance
Dilation, decrease vascular 
resistance
NO
Terminal 
arterioles, 
capillaries
Regulate insulin delivery 
to muscle. Also exchange 
nutrients, oxygen and 
hormones with muscle
Muscle glucose 
uptake, recruit muscle 
microvasculature
Insulin, muscle 
contraction, 
angiotensin GLP1, 
adiponectin
Skeletal 
muscle
Muscle contraction Increase blood flow, 
increase glucose uptake
NO, translocation of 
GLUT4 receptors
Table 1. 
Role of insulin on various vessels and mechanism.
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dense LDL), and hypertension termed the “insulin resistance syndrome”. As 
discussed, during physiological conditions, insulin binding to endothelial recep-
tors leads to phosphorylation of downstream substrates including activation of the 
IRS-1, PI3K pathway and subsequent recruitment of GLUT4 to mediate glucose 
transport into muscle and other tissues [7]. However, In the IR state, the IRS-1-
PI3K-Akt-NO pathway is muted while the MAPK pathway remains intact [8]. The 
unopposed action of ET-1 leads to a shift towards vasoconstriction, increased 
arterial stiffness, hypertension, and tissue hypoxia. In addition to this decrease 
in NO bioavailability, increases in oxidative stress, inflammatory markers, and 
pro-thrombotic mediators (i.e., increased plasma von Willebrand factor, decreased 
lipoprotein lipase activity) are seen. More direct evidence for endothelial IR was 
shown in freshly isolated arterial endothelial cells where the insulin-induced eNOS-
phosphorylation was negatively associated with oxidative stress markers [9].
During states of IR each vascular site becomes affected and contributes to an 
increase in atherosclerosis. At the level of the conduit arteries, IR causes decreased 
compliance with a concomitant increase in vessel stiffness, which is a predictor of 
coronary artery disease and stroke [10]. The impaired vasodilatory action of insulin 
on the resistance arterioles leads to decrease in blood flow to the tissues it supplies. For 
example, Baron et al. demonstrated that the inhibition of NO production (similar to 
states of IR) causes a decrease in blood flow and glucose uptake in the leg. The termi-
nal arterioles in patients with IR showed a blunted response to mixed meal in brachial 
blood flow and forearm microvascular recruitment compared to lean subjects [3].
Oxidative stress: hyperglycemia due to IR also induces generation of reactive 
oxygen species (ROS) by activation of the NADPH oxidase system. ROS acti-
vates multiple pathways linked with cell growth, proliferation and modifies NO 
bioavailability. One such pathway includes the renin-angiotensin system which 
is inappropriately activated in settings of IR. Interestingly, during continuous 
insulin infusion, Angiotensin 2 receptor antagonism resulted in whole-body insulin 
resistance and attenuation of microvasculature recruitment [5]. The mechanism 
may involve increased binding to Angiotensin 1 receptors, which have been shown 
to increases oxidative stress and cause vasoconstriction through decreased bio-
availability of eNOS and increased ROS. Chai et al. has shown that when AT2R is 
blocked, there is decreased microvascular blood flow by 80% along with reduced 
glucose extraction [11].
4. The effect of exercise on insulin resistance and vasculature
It is well established that exercise augments insulin signaling independent of 
PI3K, while the combination of skeletal muscle contraction and insulin additively 
enhances glucose transport via GLUT4 translocation. A plethora of studies have 
reported that regular physical activity is effective in patients with IR, such as type 
2 diabetes, prediabetes and metabolic syndrome, in improving glucose tolerance, 
insulin sensitivity, glycosylated hemoglobin levels (HbA1c) and morbidity and 
mortality [12]. For instance, adults with IR were found to have improvements in 
hepatic and peripheral insulin sensitivity after 12 weeks of aerobic exercise. Shorter 
term studies (i.e., 7 days) have also demonstrated similar improvements in insulin 
sensitivity in obese patients [13]. Lifestyle interventions such as diet modifications 
added to 12 weeks exercise training showed further enhancements in addition to 
insulin sensitivity including fatty acid oxidation, post-prandial hyperinsulinemia 
and systolic resting blood pressure [14].
Exercise and the endothelium: exercise causes several adaptations to IR in the 
vasculature in both the skeletal muscle and endothelium. Vessel wall shear stress 
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generated by exercise activates the PI3k/Akt/NO signaling pathway resulting in 
increased expression of eNOS and improved endothelial vasodilation and vascular 
remodeling [15]. Vessels with high shear stress are considered anti-atherogenic 
(low ET-1, high NO bioavailability) as opposed to low shear stress environments 
(high ET-1, low NO bioavailability). In patients with Type 2 diabetes, 8 weeks of 
combined aerobic and resistance exercises improved flow mediated dilation (FMD) 
of the brachial artery suggesting increased shear stress and improved endothelial 
vasodilation [16]. Exercise improved FMD, microvascular perfusion in muscles 
of older adults relative to sedentary adults in nondiabetic subjects with metabolic 
syndrome [14]. Finally, insulin sensitization without exercise also augments FMD 
in prediabetes [17].
Skeletal muscle: during exercise, blood flow to the skeletal muscle increases up to 
100-fold through vasodilation and recruitment of capillaries to help maximize oxy-
gen extraction as well as insulin delivery to the skeletal muscle [5]. Pivotal studies 
investigated the vascular effects of exercise training on insulin [7, 15, 18]. Single leg 
cycle exercises over a 10-week period improved insulin stimulated glucose uptake 
and vasodilation in the trained limb post exercise training for both healthy and IR 
subjects. Moreover, insulin stimulated vasodilation in the lower limb is greater in 
endurance trained athletes compared to otherwise healthy sedentary controls [7].
5. Endothelium and endothelial progenitor cells
Endothelial cells constitute the innermost layer of blood vessel and promote 
vascular homeostasis and angiogenesis. Endothelial cells can secrete several 
mediators that can alternatively mediate vasoconstrictors, such as endothelin-1 
and thromboxane A2, or vasodilators, such as NO, prostacyclin, and endothelium-
derived hyperpolarizing factor. Since hyperglycemia and IR can negatively impact 
NO secretion from the endothelium, with vasoconstriction, vessel wall stiffness, 
platelet aggregation and diminished angiogenesis, there is a counter-regulatory 
reparatory cellular response by circulating endothelial progenitor cells (EPCs). 
These are immature bone marrow derived cells that can differentiate into mature 
endothelial cells. These cells home in on areas that experience vascular injury or 
ischemia by way of circulating growth factors and cytokines to initiate repair of the 
endothelial surface and stimulate neovascularization and angiogenesis. In condi-
tions such as diabetes with vascular damage, the presence of diminished circulating 
EPCs constitute cellular biomarkers of compromised cardiovascular health [19]. In 
subjects with IR such as metabolic syndrome, decreased EPC number and impaired 
functionality prognosticates increased cardiovascular risk [20]. Interestingly, 
exercise promotes the production and numbers of EPCs [19, 21] putatively related 
to the anti-apoptotic effect of NO [22]. EPCs are also stimulated by exercise in 
aging studies. Moreover, the migratory function of EPCs is improved by exercise 
in subjects with IR [19, 23]. The degree of exercise dose appears to influence the 
overall EPC response [23]. In presence of insulin resistance but not overt diabetes, 
CPAP therapy improves endothelial health and EPC parameters [24].
Exercise, endothelium and fat derived mesenchymal stromal cells (MSCs): clini-
cal trials are necessary to investigate the possible cellular and molecular pathways 
that may impact endothelium and fat metabolism. Identification of the pathways 
that influence crosstalk between endothelium and fat, and thereby improve cardio-
metabolic health in the elderly and young subjects is important to identify. The 
process will help to identify genes and cell differentiation pathways that may change 
fat derived stem cell differentiation, following exercise training in the elderly and 
the young subject cohorts, which will subsequently influence the mesenchymal 
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structures of our body. Our study [25] appears to indicate that exercise promotes 
osteogenic differentiation but not myogenic differentiation in the middle-aged 
veteran population with mean age of 51 years. However, whether osteogenic differ-
entiation of adipose tissue derived mesenchymal stromal cells (MSCs) also occurs in 
young and the elderly is unknown. Myogenic differentiation in response to exercise 
is well documented [26], and different types of exercise appear to influence the 
differentiation depending on plasma-based differentiation factors [26]. However, 
the exact mechanism of how exercise modifies mesenchymal stromal cell (MSC) 
differentiation in the body needs further investigation. Prior to our recent studies, 
we would have hypothesized that exercise will promote myogenic differentiation 
in all age groups, however the differentiation of stem cells may be dependent upon 
the need of the body to regenerate a particular tissue lineage at a particular age. For 
example, exercise promotes myogenic differentiation in the young [26] whereas 
endothelial function improvement and bone regeneration may be more important 
in the elderly [27, 28].
6. Summary
Exercise is an important modifiable risk factor that significantly attenuates 
cardiovascular morbidity and mortality. Physical activity is associated with 
enhanced cardiorespiratory fitness which significantly attenuates IR, and some 
of these effects are mediated by augmented endothelial action of insulin. These 
vascular effects of exercise include an increase in endothelium-dependent vasodila-
tion through increased NO bioavailability, suppression of ET-1, increased capillary 
density, and reduction in ROS.
Finally, exercise appears to rejuvenate endothelial function by recruitment of 
exercise responsive EPCs and influences MSC differentiation.
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